ã©ãã©ã & ãããã㣠LINEã¹ã¿ã³ã
Nature å ¬å¼ãããã¥ã¼ã¹ããªãªã¸ãã«ãã£ã©ã¯ã¿ã¼ãã©ãã©ã&ããããã£ãã®LINEã¹ã¿ã³ããæ°ç»å ´ï¼
å®é¨ã大好ããªã©ãã©ãã¨ãã®ç¸æ£ããããã£ã®ã©ãã§ã®æ¥å¸¸ã¨åéºããå±ããã¾ããçãã¾ã®ã³ãã¥ã±ã¼ã·ã§ã³ãã¼ã«ã¨ãã¦æ¯éãæ´»ç¨ãã ããã
ã©ãã©ã
ã©ãã©ãã¯çç©å¦ã»ç©çå¦ãªã©ããããã®å¦ä½ãæã¤ã©ãã©ãã¼ã«ã»ã¬ããªãã¼ã®å士ç¬ãçé¢ç®ã§ããããã©ãã©ãã¯ãã©ãã«ããã£ã¦å®é¨ãç¹°ãè¿ãæ¯æ¥ãä¸å¨ç¨ã§ãã¾ããããªããã¨ãããããã©ã失æããæãã¬å¤§çºè¦ããããã¨ãã
ãã¼ãã¼ã¯ã¼ã¯ãè¦æãªã©ãã©ãã使¥ã«ç²ããæã¯ã大好ããªã³ã¼ãã¼ã§ãªãã¬ãã·ã¥ãç¸æ£ã®ããããã£ã¨ãã£ã¨ä¸ç·ã«ãããã®ã«ããã¤ãã¼ã¹ãªããããã£ã¯å¤§ãããªã£ããå°ãããªã£ãããããã«ã©ããã¸è¡ã£ã¦ãã¾ãã®ã§ãã¤ããã©ãã©ãã¦ãã¾ããæå¤ã¨æ¹åãªã³ãã
ããããã£
ã©ãã©ãã®ç¸æ£ã®ããããã£ã¯ãå°ããªéãç«ãã¤ã¿ãºã©å¥½ãã®ããããã£ã¯ãã©ãã©ãã®ã©ããæ¢æ¤ããã®ã大好ããç¹æã¯ä½ã®å¤§ãããèªå¨ã«å¤ãããã¨ãä½ãå°ãããã¦ååããã¯ããªã¢å ã§ãçãã¦ãããã
å®å®ã«ãããã¨ãå¯ããã¨ã好ããé£ãããåã®ããããã£ã¯ä½ã§ãé£ã¹ã¦ãã¾ãã ã©ãã©ãã«æ®å½±ãã¦ããã£ãã¬ã³ãã²ã³ã«ã¯ãé£ã¹ããã©ãã¯ãã¼ã«ãåã£ã¦ãã¦ãµããã¨ãããã¯ãªãã¨ã¦ãå°ãããªã£ãæã«ã©ãã©ãã®æã«æ»ããªããªã£ããã©ããããã¨ã¡ãã£ã´ãä¸å®ã«æã£ã¦ããã
Nature ã®ç§å¦è«æã«é¢é£ããã¹ã¿ã³ã
Nature ã«æ²è¼ãããç ç©¶è«æã«é¢é£ããã¹ã¿ã³ããããã¾ãã
-
On the Skin-Furrows of the Hand (1880å¹´)
ããã®æç´ã¯ä¸çå¤åãããã®ã§ã¯ãªããå人ã®èå¥ã»ç¹å®ã«å½¹ç«ã¤ãã¨ãå ±åããç ç©¶è«æã
-
On a New Kind of Rays (1896å¹´)
ç´ãæ¨ã¯ééããã人éã®éª¨ãéã¯ééããªããæ°ãã種é¡ã®æ¾å°ç·ãï¼Xç·ï¼ãçºè¦ãããã¨ãå ±åããç ç©¶è«æã
-
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid (1953å¹´)
DNAãäºéãããæ§é ã§ãããã¨ããXç·åæåçã«ãã£ã¦æç¢ºã«ç¤ºããç ç©¶è«æã
ã¹ã¿ã³ãä¸è¦§ï¼å ¨32åï¼
å¶ä½ãã¼ã
ãã©ãã©ã&ããããã£ãã¯ããã³ãã³å¨ä½ã® Nature ã·ãã¢ã»ã¤ã©ã¹ãã¬ã¼ã¿ã¼ãããã¯ã»ã¹ãã³ãµã¼ããã¶ã¤ã³ã»å¶ä½ãã¾ãããããã¯ã»ã¹ãã³ãµã¼ã¯ãNature ã«æ²è¼ããã¤ã©ã¹ã ã®å¶ä½ãæ å½ãã¦ãã¾ããQuirks of Nature ã§ã¯ãããã¯ã®å°éãçãããã¦ã¼ã¢ã¢ããµããã¤ã©ã¹ãã®æ°ã ãè¦ããã¨ãã§ãã¾ãã
å¶ä½ãã¼ã ã¡ã³ãã¼
- Artist (Nature's Senior Illustrator): Nik Spencer
- Art Director: Sou Nakamura
- Group Product Manager: Bob Edenbach
- Nature's Creative Director: Kelly Krause
ç¹å¥åå
- Wes Fernandes and Claire Welsh from Natureâs art team in London
- Teams in Tokyo
ãã£ã©ã¯ã¿ã¼å¶ä½è©±
ããã¯ã»ã¹ãã³ãµã¼
ãã©ãã«ä½ãã§ããã©ãã©ãã¼ã«ã»ã¬ããªãã¼ãã¨ããã©ãã©ãã®ã³ã³ã»ããã¯ãæ°å¹´åã«ç§ãæãããã©ãã©ãã¼ã«ãã©ãã«ä¹±å ¥ãã¦å¤§æ··ä¹±ãããã¨ããã¤ã©ã¹ãããæ¥ã¦ãã¾ããLINEã¹ã¿ã³ãã®å¶ä½ãéå§ããæãåç©ã®ãã£ã©ã¯ã¿ã¼ãããã¨èãã¦ããç§ã«ã¨ã£ã¦ã¯ã¡ããã©è¯ãåºçºç¹ã§ãããç¨ãªããã¦ããããã£ã®ã¢ã¤ãã¢ãèãã¾ãããä¸ã®ããããã£ã®ã¤ã©ã¹ãã¯ç§ãæåã«ã¹ã±ãããããã®ã§ããããã¥ã¼ãã§æãããéãç«ãã¨ããåæã®ã¤ã¡ã¼ã¸ã¯ãæå¾ã¾ã§ã»ã¨ãã©å¤ãããã¨ã¯ããã¾ããã§ãããã©ãã©ãã®ãã¶ã¤ã³ã¯ããããã£ã»ã©å®¹æã§ã¯ãªããæéãããã¦é²åããã¦ããã¾ããã
çºæ³ã®å ã¨ãªã£ãã¤ã©ã¹ã
ã©ãã©ãã®ãã£ã©ã¯ã¿ã¼ãã¶ã¤ã³ãã§ããã¾ã§
ããããã£æåã®ã¹ã±ãã
ã¹ã¿ã³ãã®ãã¶ã¤ã³ã«ã¤ãã¦ã¯ãå¶ä½ãã¼ã ã¨ã¢ã¤ãã¢ãåºãåã£ã¦ãã¾ãã¾ãªã·ããªãªãæºåããç¹°ãè¿ã話ãåããã¨ã§ä½ãä¸ãã¾ããããã®éç¨ã§ãç§èªèº«ãã©ãã©ãã¨ããããã£ã®é¢ä¿æ§ããã£ã©ã¯ã¿ã¼ãã¶ã¤ã³ãå¾ã ã«çºå±ããã¦ããã¾ãããã©ãã©ãã¯ãã¬ã³ããªã¼ã§åãè ã®ï¼ã ãã©ã¡ãã£ã¨æãã£ã½ãï¼ç§å¦è ãããããã£ã¯ååããå®å®ã¾ã§ãç§å¦ãæ¢æ±ã§ããã¨ãããªãä½å¦ã¸ã§ãåéºã«åºããã¾ãã
ã©ã®ã¢ã¤ãã¢ãã¹ã¿ã³ãã«æ¡ç¨ããã©ã®ã¢ã¤ãã¢ãæ¡ç¨ããªãããæ±ºãã使¥ã¯ç°¡åã§ã¯ããã¾ããã§ãããç§å¦è ã¯æ®æ®µã®çæ´»ã§ã©ã®ããã«ã¹ã¿ã³ãã使ãã ãããã¨ãããã¨ã«ã¤ãã¦ä½åº¦ããã¼ã ã§èãã¾ããããã®çµæãç§å¦çè¦ç´ ãåãå ¥ãã¤ã¤ãä¸è¬çãªä¼è©±ã«ã使ããããã¹ã¿ã³ãã«ãããã¨ããçµè«ã«è³ãã¾ãããå¶ä½æéãæ°åã³ããã¦ã¤ã«ã¹ã®æµè¡ã¨éãªã£ã¦ãããã¨ãå½±é¿ããCOVID-19ã«é¢é£ããã¹ã¿ã³ããå«ãããã¨ã«ãã¾ãããçãã¾ã«æ¥½ããã§ããã ããã¹ã¿ã³ãã«ãªãã°ãã¼ã ä¸åå¬ããæãã¾ãï¼
åçã®å¯ä»ã«ã¤ãã¦
ãã¤ãã£ã¼ã»ã¸ã£ãã³æ ªå¼ä¼ç¤¾ãå¾ãLINEã¹ã¿ã³ãã®åçã¯ãæ¥æ¬ã®å¦çã®é«çæè²ãæ¯æ´ããå£ä½ã«å ¨é¡å¯ä»ããã¦ããã ãäºå®ã§ãããã®åãçµã¿ãç§å¦è ãå¿ãå¦çã®ä¸å©ã¨ãªãã°å¹¸ãã§ãã
2021å¹´ å¯ä»å®ç¸¾
æ¥æ¬è²¡å£ 夢ã®å¥¨å¦éï¼6,470åï¼ã¹ã¿ã³ãã®å£²ä¸ããçºçããå¼ç¤¾ã¸ã®åé éåãåãåå ¨é¡ï¼
